NYSE
HUM
Last Price
US $396.75
KEY FIGURES
MKT CAP
$46.1B
EPS
TTM
$9.39
PEG
TTM
N/M
P/E
TTM
40.92x
P/S
TTM
0.36x
YIELD
0.92%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Humana Inc. cash flow to debt ratio of 7.12% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Humana Inc.'s free cash flow has decreased -84.32% from $2.39G last year to $375.00M, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Humana Inc.'s debt to equity ratio is 0.75, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Humana Inc.'s debt has increased relative to shareholder equity from 0.75 last year to 0.75 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Humana Inc. has a net debt to EBITDA ratio of 3.00x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Humana Inc.'s interest coverage ratio of 2.08 indicates that earnings with margin can cover interest payments on company debt
Financial risk - Profit margin growth.
Humana Inc.'s profit margin has decreased (-19.61%) in the last year from 1.02% to 0.82%, signaling decreasing performance
Financial risk - Short term assets vs short term liabilities.
Humana Inc.'s short-term liabilities of $10.31G exceed its short-term assets of $7.47G, signaling financial risk
Decreasing performance - ROA.
Humana Inc.'s return on assets of 2.04% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Humana Inc.'s return on equity of 6.19%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Humana Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Humana Inc. had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Humana Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Decreasing performance - FCF yield.
Humana Inc. has a free cash flow yield of 0.81%, which is below the 2.00% threshold, indicating limited cash return relative to market value
Decreasing performance - Healthy earnings growth.
Humana Inc.'s yearly earnings has decreased -1.57% since last year from $1.21G to $1.19G, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Humana Inc.'s yearly revenue has increased 10.11% since last year from $117.76G to $129.66G, signaling increasing performance
Decreasing performance - ROIC.
ROIC 3.23% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Humana Inc.'s 3-year revenue CAGR of 11.75% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Humana Inc. had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Humana Inc. had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Humana Inc. has insufficient data to evaluate this check.
Overvalued - Earnings yield.
Humana Inc. has an earnings yield of 2.45%, which is below the 4.00% threshold, indicating the stock may be expensive relative to its earnings
Overvalued - EBITDA valuation.
Humana Inc. is overvalued relative to its fair value price of 96.35 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Humana Inc. has an EV/EBITDA ratio of 19.34x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Humana Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Humana Inc. has a price-to-book ratio of 2.49x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Humana Inc. has a price-to-sales ratio of 0.34x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
6.19%
Return on equity
ROIC: 3.23%
Valuation History
40.9X
Price to Earnings
EV/EBITDA: 19.3X
Cash flow
Profit margin
10.93%
(FY vs FY)
EBITDA Y/Y
-12.20%
(FY vs FY)
Cash flow Y/Y
-39.63%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $396.75
—
Default assumptions
EBITDA Multiple
Fair Value
Market $396.75
-75.72%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.